CLASS I Drug recall · Reported 22 Jan 2020 · FDA Enforcement Report

Panther Platinum, in green, black background with white recalled

Motto International is recalling Panther Platinum, in green, black background with white, red text in hologram paper, distributed in Texas. The recall was initiated on 17 Dec 2019 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesAll lots remaining within expiry.
Quantity recalled1 box

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0657-2020
FDA event ID
84526
Recalling firm
Motto International, Dallas, TX
Classification
Class I
Status
Terminated
Recall initiated
17 Dec 2019
FDA classified
10 Jan 2020
Reported
22 Jan 2020
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Packaging Defects

Timeline

17 Dec 2019Recall initiated by company
10 Jan 2020Classified by FDA+24 days
22 Jan 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX

Where it was distributed

TX

Texas

Questions about this recall

Is Panther Platinum, in green, black background with white, red text in hologram paper recalled?

Yes. Motto International recalled Panther Platinum, in green, black background with white, red text in hologram paper on 17 Dec 2019. The recall is Class I and its status is Terminated. Recall number D-0657-2020.

Why was it recalled?

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Which lots are affected?

All lots remaining within expiry.

Where was it sold?

TX

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Motto International

All 4